242 related articles for article (PubMed ID: 1129845)
1. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
Simmons RL; Rios A
Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
[No Abstract] [Full Text] [Related]
2. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
Simmons RL; Rios A
Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
[No Abstract] [Full Text] [Related]
3. Neuraminidase treated cells and their role in cancer immunotherapy.
Simmons RL; Rios A
Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
[No Abstract] [Full Text] [Related]
4. Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A.
Simmons RL; Rios A
Cancer; 1974 Oct; 34(4 Suppl):suppl:1541-7. PubMed ID: 4138077
[No Abstract] [Full Text] [Related]
5. Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells.
Rios A; Simmons RL
Int J Cancer; 1974 Jan; 13(1):71-81. PubMed ID: 4818273
[No Abstract] [Full Text] [Related]
6. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
Simmons RL; Rios A
Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
[No Abstract] [Full Text] [Related]
7. Experimental and clinical trials with BCG immunotherapy.
Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
[No Abstract] [Full Text] [Related]
8. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
Rios A; Simmons RL
Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
[No Abstract] [Full Text] [Related]
9. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
Simmons RL; Rios A
Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
[No Abstract] [Full Text] [Related]
10. Experimental cancer immunotherapy using a neuraminidase-treated non-viable frozen tumor vaccine.
Rios A; Simmons RL
Surgery; 1974 Apr; 75(4):503-7. PubMed ID: 4840798
[No Abstract] [Full Text] [Related]
11. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
[No Abstract] [Full Text] [Related]
12. [Use of the enzyme neuraminidase for immunotherapeutic treatment of chemically induced carcinogenesis].
Maĭskiĭ IN; Aĭrapet'ian GP; Kobrinskiĭ GD; Troitskaia NA; Gudkova GB
Biull Eksp Biol Med; 1977 Dec; 84(12):714-7. PubMed ID: 413595
[TBL] [Abstract][Full Text] [Related]
13. Regression of established methylcholanthrene tumors by intratumor injections of Vbrio cholerae neuraminidase.
Simmons RL; Rios A; Ray PK
J Surg Oncol; 1972; 4(4):298-305. PubMed ID: 5083567
[No Abstract] [Full Text] [Related]
14. Horizons in tumor immunology. A seminar.
Wilson RE; Alexander P; Rosenberg SA; Simmons RL
Arch Surg; 1974 Jul; 109(1):17-29. PubMed ID: 4834133
[No Abstract] [Full Text] [Related]
15. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
Song CW; Levitt SH
Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
[No Abstract] [Full Text] [Related]
16. Regional lymphatics and the mechanism of action of neuraminidase.
Ziegler MM; Miller EE; Barker CF
Surg Forum; 1973; 24():290-2. PubMed ID: 4806011
[No Abstract] [Full Text] [Related]
17. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
[No Abstract] [Full Text] [Related]
18. Spontaneous mammary tumors in mongrel dogs. A relevant model to demonstrate tumor therapeutical success by application of neuraminidase-treated tumor cells.
Sedlacek HH; Seiler FR
Dev Biol Stand; 1977 Apr 13-15; 38():399-412. PubMed ID: 608530
[No Abstract] [Full Text] [Related]
19. Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas.
Simmons RL; Rios A
J Immunol; 1973 Dec; 111(6):1820-5. PubMed ID: 4750868
[No Abstract] [Full Text] [Related]
20. Immuno-therapy of methyl cholanthrene induced and spontaneous tumors in mice by use of tumor vaccine, neuraminidase and BCG.
Gautam S; Aikat BK
Indian J Med Res; 1976 Mar; 64(3):472-81. PubMed ID: 965048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
